Novo's main Ozempic plant cited for quality lapses by FDA


Novo has been racing to boost supplies of its drugs for obesity and diabetes after initially underestimating demand.... Read more

Bron: Fortune
Tags:
Geplaatst: 29 Oct 2024 - 23:47